Wayne A. Johnson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wayne A. Johnson has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Michael G. Anderson
Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA, USA
8 shared publications - Michael J. Welsh
University of Iowa
5 shared publications - Toshihiro Kitamoto
Interdisciplinary Graduate Program in Genetics, University of Iowa, Iowa City, USA
5 shared publications - Andrew F. Russo
University of Iowa
4 shared publications Joshua A. Ainsley
Department of Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA
4 shared publicationsKaan Certel
C Department of Molecular Physiology and Biophysics , University of Iowa , Iowa City , IA , USA
3 shared publications
Latest Publications
- Open Access
Drosophila glutathione S-transferase S1 exacerbates phenotypes of the gain-of-function voltage-gated sodium channel mutant para Shu through a hemocyte-mediated mechanism
Drosophila glutathione S-transferase S1 (GstS1) is a unique member of the glutathione S-transferase family and is considered the ortholog of vertebrate hematopoietic prostaglandin D synthase based on amino acid sequence similarity. A previous forward genetic screen revealed that a null mutation in GstS1 dominantly suppresses genetically induced behavioral hyperexcitability in several seizure-prone Drosophila mutants, including para Shu , a gain-of-function mutant of the voltage-gated sodium channel gene paralytic ( para ), and eas 2 , a loss-of-function mutant of the ethanolamine kinase gene easily shocked ( eas ). Here, using the GAL4/UAS system combined with GstS1 RNAi, we show that hemocyte-specific GstS1 knockdown suppresses hyperexcitable phenotypes in both para Shu and eas 2 . Notably, suppression of adult para Shu phenotypes required GstS1 knockdown before adult eclosion, suggesting that GstS1 modulates adult neuronal excitability by influencing neural development through neuroimmune interactions. Consistent with this model, hemocyte-specific GstS1 knockdown rescued abnormal dendritic morphology in developing class IV dendritic arborization (C4da) neurons of para Shu larvae. Moreover, para Shu and eas 2 larvae exhibited increased numbers of sessile hemocytes surrounding C4da neuron somata, a phenotype reversed by either GstS1 knockdown or dietary supplementation with the ω-3 polyunsaturated fatty acid α-linolenic acid. Together, these findings reveal a previously unrecognized developmental role for GstS1 in promoting nervous system hyperexcitability through hemocyte-mediated neuroimmune interactions, potentially involving bioactive lipid signaling. Our results highlight neuroimmune crosstalk as an important mechanism linking genetic perturbations to altered neural development and seizure-associated hyperexcitability.
Open AccessDrosophila glutathione S-transferase S1 exacerbates phenotypes of the gain-of-function voltage-gated sodium channel mutant para Shu through a hemocyte-mediated mechanism
Drosophila glutathione S-transferase S1 (GstS1) is a unique member of the glutathione S-transferase family and is considered the ortholog of vertebrate hematopoietic prostaglandin D synthase based on amino acid sequence similarity. A previous forward genetic screen revealed that a null mutation in GstS1 dominantly suppresses genetically induced behavioral hyperexcitability in several seizure-prone Drosophila mutants, including para Shu , a gain-of-function mutant of the voltage-gated sodium channel gene paralytic ( para ), and eas 2 , a loss-of-function mutant of the ethanolamine kinase gene easily shocked ( eas ). Here, using the GAL4/UAS system combined with GstS1 RNAi, we show that hemocyte-specific GstS1 knockdown suppresses hyperexcitable phenotypes in both para Shu and eas 2 . Notably, suppression of adult para Shu phenotypes required GstS1 knockdown before adult eclosion, suggesting that GstS1 modulates adult neuronal excitability by influencing neural development through neuroimmune interactions. Consistent with this model, hemocyte-specific GstS1 knockdown rescued abnormal dendritic morphology in developing class IV dendritic arborization (C4da) neurons of para Shu larvae. Moreover, para Shu and eas 2 larvae exhibited increased numbers of sessile hemocytes surrounding C4da neuron somata, a phenotype reversed by either GstS1 knockdown or dietary supplementation with the ω-3 polyunsaturated fatty acid α-linolenic acid. Together, these findings reveal a previously unrecognized developmental role for GstS1 in promoting nervous system hyperexcitability through hemocyte-mediated neuroimmune interactions, potentially involving bioactive lipid signaling. Our results highlight neuroimmune crosstalk as an important mechanism linking genetic perturbations to altered neural development and seizure-associated hyperexcitability.
- 31 March 2023
- Published by Elsevier in Neuroscience
- Vol. 520, 1-17
Dietary Supplementation with Milk Lipids Leads to Suppression of Developmental and Behavioral Phenotypes of Hyperexcitable Drosophila Mutants
- 31 March 2023
- Published by Elsevier in Neuroscience
- Vol. 520, 1-17
Dietary Supplementation with Milk Lipids Leads to Suppression of Developmental and Behavioral Phenotypes of Hyperexcitable Drosophila Mutants
- 1 November 2019
- Published by The University of Iowa
Exploring the relationship between circadian neuron activity patterns and behavioral output in Drosophila
Circadian clocks drive the daily patterns of behavior and physiology observed in most organisms. These internal clocks allow organisms to advantageously align their behavior to daily cycles in the environment such as light and temperature. The fruit fly Drosophila displays many robust, daily behavioral rhythms including discrete bouts of locomotor activity at dawn (i.e. morning activity) and dusk (i.e. evening activity). The molecular clocks that drive these daily activity bouts are found in approximately 150 circadian pacemaker neurons in the fly brain. Interestingly, the timing of the molecular clocks is synchronous between all pacemaker neurons, yet different subsets of these neurons appear to make quite different contributions to the regulation of morning vs. evening activity. It remains poorly understood how the molecular circadian clock drives daily rhythms in pacemaker neuron activity or how the activities of different groups of pacemaker neurons combine to produce complex behavioral output.The overall goal of this thesis is to characterize how different subsets of Drosophila pacemaker neurons contribute to daily behavioral regulation both individually and as a network. To examine daily patterns of neuronal activity in different groups of circadian clock neurons, we have established imaging methods using genetically encoded fluorescent sensors. For these sensors, changes in fluorescence levels correspond to changes in neuronal activity, thus allowing us to measure neuronal activity patterns in real-time and throughout the day. Using these tools, I have characterized the daily activity patterns of different groups of the clock neurons that agree with published rhythms in activity as assessed by patch-clamp electrophysiology and calcium imagingWe have also used genetic and molecular approaches such as RNA interference (RNAi) to alter gene expression in a tissue-specific manner. These approaches allow us to manipulate the function of different groups of clock neurons and to determine how these manipulations affect rhythmic behavior and neuronal activity patterns. We have silenced different subsets of circadian pacemaker neurons using RNAi knockdown of the NARROW ABDOMEN (NA) sodium leak channel and identified a complex role for a subset of the posterior dorsal neurons 1 (DN1p) in regulating locomotor behavior. The DN1p are known to be involved in promoting morning behavior, and recent studies have shown that a subset of the DN1p regulate midday sleep bouts via downstream sleep regulating neurons. Our data suggest that the DN1p neurons likely suppress midday activity through inhibition of other circadian pacemaker neurons, and that this inhibitory role can be compensated for by light.Finally, we have also examined the intracellular mechanisms regulating circadian neuronal output. Rhythmic activity of the NA leak channel and its mammalian ortholog (NALCN) have been shown to contribute to daily excitability rhythms in circadian pacemaker neurons. We used temporally-restricted expression of RNAi and rescue constructs to identify a developmental requirement for the NA channel complex in Drosophila, and we demonstrate that channel complex proteins are very stable in the Drosophila brain. These data suggest that circadian regulation of the NA channel in adults may involve post-translational mechanisms that control activity and not just expression of the channel complex.
- 1 November 2019
- Published by The University of Iowa
Exploring the relationship between circadian neuron activity patterns and behavioral output in Drosophila
Circadian clocks drive the daily patterns of behavior and physiology observed in most organisms. These internal clocks allow organisms to advantageously align their behavior to daily cycles in the environment such as light and temperature. The fruit fly Drosophila displays many robust, daily behavioral rhythms including discrete bouts of locomotor activity at dawn (i.e. morning activity) and dusk (i.e. evening activity). The molecular clocks that drive these daily activity bouts are found in approximately 150 circadian pacemaker neurons in the fly brain. Interestingly, the timing of the molecular clocks is synchronous between all pacemaker neurons, yet different subsets of these neurons appear to make quite different contributions to the regulation of morning vs. evening activity. It remains poorly understood how the molecular circadian clock drives daily rhythms in pacemaker neuron activity or how the activities of different groups of pacemaker neurons combine to produce complex behavioral output.The overall goal of this thesis is to characterize how different subsets of Drosophila pacemaker neurons contribute to daily behavioral regulation both individually and as a network. To examine daily patterns of neuronal activity in different groups of circadian clock neurons, we have established imaging methods using genetically encoded fluorescent sensors. For these sensors, changes in fluorescence levels correspond to changes in neuronal activity, thus allowing us to measure neuronal activity patterns in real-time and throughout the day. Using these tools, I have characterized the daily activity patterns of different groups of the clock neurons that agree with published rhythms in activity as assessed by patch-clamp electrophysiology and calcium imagingWe have also used genetic and molecular approaches such as RNA interference (RNAi) to alter gene expression in a tissue-specific manner. These approaches allow us to manipulate the function of different groups of clock neurons and to determine how these manipulations affect rhythmic behavior and neuronal activity patterns. We have silenced different subsets of circadian pacemaker neurons using RNAi knockdown of the NARROW ABDOMEN (NA) sodium leak channel and identified a complex role for a subset of the posterior dorsal neurons 1 (DN1p) in regulating locomotor behavior. The DN1p are known to be involved in promoting morning behavior, and recent studies have shown that a subset of the DN1p regulate midday sleep bouts via downstream sleep regulating neurons. Our data suggest that the DN1p neurons likely suppress midday activity through inhibition of other circadian pacemaker neurons, and that this inhibitory role can be compensated for by light.Finally, we have also examined the intracellular mechanisms regulating circadian neuronal output. Rhythmic activity of the NA leak channel and its mammalian ortholog (NALCN) have been shown to contribute to daily excitability rhythms in circadian pacemaker neurons. We used temporally-restricted expression of RNAi and rescue constructs to identify a developmental requirement for the NA channel complex in Drosophila, and we demonstrate that channel complex proteins are very stable in the Drosophila brain. These data suggest that circadian regulation of the NA channel in adults may involve post-translational mechanisms that control activity and not just expression of the channel complex.
- Open Access
- 4 March 2019
- Published by The University of Iowa
Bidirectional communication between the brain and gut microbiota in Shudderer, a Drosophila Nav channel mutant
Neurological disorders, such as epilepsy, often result from inherited or newly acquired genetic mutations. However, individuals possessing the exact same disease-causing mutations can exhibit dramatic differences in the severity of their symptoms. These differences can be explained in part by environmental factors, such as the microbes in our gut, that play an important role in the manifestation of disease symptoms. Within the last decade, microbes living in the gut have established themselves as an environmental factor with profound effects on our health and well-being. Of special interest is the relationship between the gut microbiota and neurological disease. The goal of my thesis was to: 1) characterize the gut microbiota composition and 2) understand how the gut microbiota modulates seizure-like behavior using Shudderer, a fruit fly (Drosophila melanogaster) model of epilepsy. Shudderer flies possess a mutation in the voltage-gated sodium channel gene and display seizure-like behavioral abnormalities including spontaneous tremors and heat-induced seizures. We identified differences in the microbial composition of the gut microbiota between Shudderer and control (healthy) flies. We also found that by removing the gut microbiota we could improve seizure-like behavior of Shudderer flies as well as another Drosophila mutant harboring a similar genetic mutation. Together, these findings provide evidence that a bidirectional interaction exists between the gut microbiota and neurological function. Since the molecular and cellular mechanisms controlling basic biological processes are highly conserved between fruit flies and humans, these findings are expected to be applicable to mammalian systems, including humans, and may lead to the future development of novel therapeutics to treat epilepsy and other neurological disorders.
- 4 March 2019
- Published by The University of Iowa
Open AccessBidirectional communication between the brain and gut microbiota in Shudderer, a Drosophila Nav channel mutant
Neurological disorders, such as epilepsy, often result from inherited or newly acquired genetic mutations. However, individuals possessing the exact same disease-causing mutations can exhibit dramatic differences in the severity of their symptoms. These differences can be explained in part by environmental factors, such as the microbes in our gut, that play an important role in the manifestation of disease symptoms. Within the last decade, microbes living in the gut have established themselves as an environmental factor with profound effects on our health and well-being. Of special interest is the relationship between the gut microbiota and neurological disease. The goal of my thesis was to: 1) characterize the gut microbiota composition and 2) understand how the gut microbiota modulates seizure-like behavior using Shudderer, a fruit fly (Drosophila melanogaster) model of epilepsy. Shudderer flies possess a mutation in the voltage-gated sodium channel gene and display seizure-like behavioral abnormalities including spontaneous tremors and heat-induced seizures. We identified differences in the microbial composition of the gut microbiota between Shudderer and control (healthy) flies. We also found that by removing the gut microbiota we could improve seizure-like behavior of Shudderer flies as well as another Drosophila mutant harboring a similar genetic mutation. Together, these findings provide evidence that a bidirectional interaction exists between the gut microbiota and neurological function. Since the molecular and cellular mechanisms controlling basic biological processes are highly conserved between fruit flies and humans, these findings are expected to be applicable to mammalian systems, including humans, and may lead to the future development of novel therapeutics to treat epilepsy and other neurological disorders.
- 29 November 2018
- Published by The University of Iowa
Elucidating the molecular and biophysical determinants that suppress Ca2+-dependent facilitation of Cav2.2 Ca2+ channels
Cav2.2 channels are presynaptic voltage-gated Ca2+ channels that regulate neurotransmitter release. In addition, they are major therapeutic targets from neuropathic pain, a chronic pain disorder caused by injury to the nerve. Pain-relieving drugs such as opioids and ziconotide block Cav2.2 channels. Unfortunately, these drugs are associated with severe adverse side effects. Therefore, there is a need to understand the factors that regulate Cav2.2 channels to design more effective therapies. My dissertation uses electrophysiological techniques to understand the factors that regulate Cav2.2 channel function. My research will provide insights into how Cav2.2 channels integrate diverse cellular signals to shape neurotransmission. This knowledge can be used to treat neurological disorders, such as chronic pain and Myoclonus- Dystonia syndrome, a movement disorder associated with a mutation in the gene that encodes Cav2.2. A variety of regulatory mechanisms modulate Ca2+ entry through Cav2.2 channels. One prominent from of regulation is Ca2+-dependent inactivation, a negative feedback mechanism. Incoming Ca2+ ions bind to the Ca2+ sensor calmodulin, which is tethered to the channel. The interaction between Ca2+ and calmodulin is thought to induce a conformational change in the structure of Cav2.2 to reduce further Ca2+ entry. The related voltage-gated Ca2+ channel Cav2.1 undergoes an additional and opposing form of regulation, Ca2+-dependent facilitation, which enhances Ca2+ entry. Ca2+-dependent inactivation and facilitation of Cav2.1 can adjust the amount of neurotransmitter released at a synapse in ways that modify information processing in the nervous system. Unlike Cav2.1, Cav2.2 does not undergo Ca2+-dependent facilitation, but the mechanism underlying this difference is unknown. One possibility is that Cav2.2 channels do not contain the molecular components necessary to support Ca2+-dependent facilitation, which have been identified in Cav2.1 in previous studies. I hypothesized that the analogous regions of Cav2.2 contain slight modifications, which prevents Ca2+-dependent facilitation. In support of this hypothesis, I found that Cav2.2 channels can undergo Ca2+-dependent facilitation upon transferring portions of the C-terminal domain of Cav2.1 to Cav2.2. A second possibility is that Cav2.2 undergoes other forms of regulation that oppose Ca2+-dependent facilitation. Cav2.2 is strongly inhibited by ligands for some G protein-coupled receptors, which helps prevent excess release of neurotransmitters in the nervous system. I hypothesized that strong G protein modulation of Cav2.2 opposes Ca2+-dependent facilitation. I found that Cav2.2 channels could undergo a form of Ca2+-dependent facilitation upon inhibiting G-protein signaling, which supported my hypothesis. Taken together, my results demonstrate that multiple factors contribute the lack of Ca2+-dependent facilitation observed for Cav2.2 channels. My results provide new insights into the intrinsic and extrinsic forces that regulate Cav2.2 function, which expands our understanding of how Cav2.2-mediated Ca2+ signals can modified by normal patterns of neuronal activity. This knowledge will aid our understanding of the pathogenic mechanisms underlying neurological conditions associated with Cav2.2 dysfunction and how to treat them.
- 29 November 2018
- Published by The University of Iowa
Elucidating the molecular and biophysical determinants that suppress Ca2+-dependent facilitation of Cav2.2 Ca2+ channels
Cav2.2 channels are presynaptic voltage-gated Ca2+ channels that regulate neurotransmitter release. In addition, they are major therapeutic targets from neuropathic pain, a chronic pain disorder caused by injury to the nerve. Pain-relieving drugs such as opioids and ziconotide block Cav2.2 channels. Unfortunately, these drugs are associated with severe adverse side effects. Therefore, there is a need to understand the factors that regulate Cav2.2 channels to design more effective therapies. My dissertation uses electrophysiological techniques to understand the factors that regulate Cav2.2 channel function. My research will provide insights into how Cav2.2 channels integrate diverse cellular signals to shape neurotransmission. This knowledge can be used to treat neurological disorders, such as chronic pain and Myoclonus- Dystonia syndrome, a movement disorder associated with a mutation in the gene that encodes Cav2.2. A variety of regulatory mechanisms modulate Ca2+ entry through Cav2.2 channels. One prominent from of regulation is Ca2+-dependent inactivation, a negative feedback mechanism. Incoming Ca2+ ions bind to the Ca2+ sensor calmodulin, which is tethered to the channel. The interaction between Ca2+ and calmodulin is thought to induce a conformational change in the structure of Cav2.2 to reduce further Ca2+ entry. The related voltage-gated Ca2+ channel Cav2.1 undergoes an additional and opposing form of regulation, Ca2+-dependent facilitation, which enhances Ca2+ entry. Ca2+-dependent inactivation and facilitation of Cav2.1 can adjust the amount of neurotransmitter released at a synapse in ways that modify information processing in the nervous system. Unlike Cav2.1, Cav2.2 does not undergo Ca2+-dependent facilitation, but the mechanism underlying this difference is unknown. One possibility is that Cav2.2 channels do not contain the molecular components necessary to support Ca2+-dependent facilitation, which have been identified in Cav2.1 in previous studies. I hypothesized that the analogous regions of Cav2.2 contain slight modifications, which prevents Ca2+-dependent facilitation. In support of this hypothesis, I found that Cav2.2 channels can undergo Ca2+-dependent facilitation upon transferring portions of the C-terminal domain of Cav2.1 to Cav2.2. A second possibility is that Cav2.2 undergoes other forms of regulation that oppose Ca2+-dependent facilitation. Cav2.2 is strongly inhibited by ligands for some G protein-coupled receptors, which helps prevent excess release of neurotransmitters in the nervous system. I hypothesized that strong G protein modulation of Cav2.2 opposes Ca2+-dependent facilitation. I found that Cav2.2 channels could undergo a form of Ca2+-dependent facilitation upon inhibiting G-protein signaling, which supported my hypothesis. Taken together, my results demonstrate that multiple factors contribute the lack of Ca2+-dependent facilitation observed for Cav2.2 channels. My results provide new insights into the intrinsic and extrinsic forces that regulate Cav2.2 function, which expands our understanding of how Cav2.2-mediated Ca2+ signals can modified by normal patterns of neuronal activity. This knowledge will aid our understanding of the pathogenic mechanisms underlying neurological conditions associated with Cav2.2 dysfunction and how to treat them.
- 29 November 2018
- Published by The University of Iowa
A tale of two genes controlling behavior in Drosophila
Substance abuse and mental health disorders are a leading source of years lost to disability from medical causes worldwide. Unfortunately, for most neurological disorders it is unclear how underlying genetic predispositions govern behavioral response to environmental stressors. Owing to their convenience, genetic tractability, and small brains, the fruit fly, Drosophila melanogaster, has become an invaluable model in which to dissect the neurological basis of conserved complex behaviors. Here, I characterized the respective roles of two genes in alcohol response and sleep behavior.Steroid hormones profoundly influence behavioral response to alcohol, yet the role of unconventional non-genomic steroid signaling in this process is unknown. I discovered that Drosophila DopEcR, a G-protein coupled receptor (GPCR) activated by dopamine or the major insect steroid hormone ecdysone, plays a critical role in ethanol-induced behaviors. DopEcR mutants took longer to sedate when exposed to ethanol vapor, and post-eclosion expression of DopEcR-RNAi phenocopied mutant resistance. DopEcR was necessary in particular neuronal subsets, including cholinergic and peptidergic neurons, and promoted ethanol sedation by suppressing epidermal growth factor/extracellular signal-regulated kinase signaling. In adult flies, ecdysone negatively regulated DopEcR-mediated ethanol-induced sedation. We also found that DopEcR inhibits ethanol-induced locomotion, a conserved dopaminergic behavior. Together, these findings provide novel insight into how an unconventional steroid GPCR interacts with multiple downstream signaling cascades to fine tune behavioral response to alcohol.Despite an established link between epilepsy and sleep behavior, it remains unclear how epileptogenic mutations affect sleep and seizure susceptibility. To address this, I examined the rest/wake behavior of two fly models of epilepsy with paralytic voltage-gated sodium channel mutations known to cause human generalized epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS). GEFS+ and DS flies display heat-induced seizure susceptibility, but at normal temperatures I found that both mutants had exaggerated nighttime sleep behavior. GEFS+ sleep was more resistant to pharmacologic and genetic reduction of GABA transmission as compared to control’s response. This finding is consistent with augmented GABAergic suppression of wake-promoting pigment-dispersing factor (PDF) neurons in GEFS+ mutants. Contrastingly, DS sleep was almost completely resistant to pharmacologic GABA reduction, suggesting that PDF neurons are incapable of functioning despite disinhibition. The sleep of both GEFS+ and DS flies was largely suppressed, but not eliminated, by scotophase light, highlighting the importance of light stimulus and circadian signals in the manifestation of their phenotypes. Following sleep deprivation, GEFS+ and DS mutants failed show to homeostatic rebound. Sleep loss also unexpectedly reduced the seizure susceptibility of GEFS+ flies. This study revealed the sleep architecture of Drosophila voltage-gated sodium channel mutants and provides a unique platform in which to further study the sleep/epilepsy relationship.
- 29 November 2018
- Published by The University of Iowa
A tale of two genes controlling behavior in Drosophila
Substance abuse and mental health disorders are a leading source of years lost to disability from medical causes worldwide. Unfortunately, for most neurological disorders it is unclear how underlying genetic predispositions govern behavioral response to environmental stressors. Owing to their convenience, genetic tractability, and small brains, the fruit fly, Drosophila melanogaster, has become an invaluable model in which to dissect the neurological basis of conserved complex behaviors. Here, I characterized the respective roles of two genes in alcohol response and sleep behavior.Steroid hormones profoundly influence behavioral response to alcohol, yet the role of unconventional non-genomic steroid signaling in this process is unknown. I discovered that Drosophila DopEcR, a G-protein coupled receptor (GPCR) activated by dopamine or the major insect steroid hormone ecdysone, plays a critical role in ethanol-induced behaviors. DopEcR mutants took longer to sedate when exposed to ethanol vapor, and post-eclosion expression of DopEcR-RNAi phenocopied mutant resistance. DopEcR was necessary in particular neuronal subsets, including cholinergic and peptidergic neurons, and promoted ethanol sedation by suppressing epidermal growth factor/extracellular signal-regulated kinase signaling. In adult flies, ecdysone negatively regulated DopEcR-mediated ethanol-induced sedation. We also found that DopEcR inhibits ethanol-induced locomotion, a conserved dopaminergic behavior. Together, these findings provide novel insight into how an unconventional steroid GPCR interacts with multiple downstream signaling cascades to fine tune behavioral response to alcohol.Despite an established link between epilepsy and sleep behavior, it remains unclear how epileptogenic mutations affect sleep and seizure susceptibility. To address this, I examined the rest/wake behavior of two fly models of epilepsy with paralytic voltage-gated sodium channel mutations known to cause human generalized epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS). GEFS+ and DS flies display heat-induced seizure susceptibility, but at normal temperatures I found that both mutants had exaggerated nighttime sleep behavior. GEFS+ sleep was more resistant to pharmacologic and genetic reduction of GABA transmission as compared to control’s response. This finding is consistent with augmented GABAergic suppression of wake-promoting pigment-dispersing factor (PDF) neurons in GEFS+ mutants. Contrastingly, DS sleep was almost completely resistant to pharmacologic GABA reduction, suggesting that PDF neurons are incapable of functioning despite disinhibition. The sleep of both GEFS+ and DS flies was largely suppressed, but not eliminated, by scotophase light, highlighting the importance of light stimulus and circadian signals in the manifestation of their phenotypes. Following sleep deprivation, GEFS+ and DS mutants failed show to homeostatic rebound. Sleep loss also unexpectedly reduced the seizure susceptibility of GEFS+ flies. This study revealed the sleep architecture of Drosophila voltage-gated sodium channel mutants and provides a unique platform in which to further study the sleep/epilepsy relationship.
- 29 November 2018
- Published by The University of Iowa
Regulation of CGRP gene expression and effects on light aversive behavior
Migraine is a debilitating neurological disorder, which affects over 10% of the general population. In addition to headache, migraine includes a host of associated symptoms, such as nausea and hypersensitivity to light, noise, and touch. While great strides have been made in migraine treatment in recent decades, the basic biological and pathophysiological mechanisms underlying migraine are still not well understood. Pain signals travel via a polysynaptic pathway from the periphery to the cortex, where conscious perception of pain occurs. This multi-neuron pathway produces a message that can be modified at any step of its transit. One peptide that may modify this pathway is calcitonin gene-related peptide (CGRP). CGRP is a potent vasodilator and neuromodulator, and mounting evidence suggests CGRP may play a causative role in migraine. CGRP levels are increased during migraine, but can be reduced upon successful treatment with drugs in the triptan class. Importantly, injection of CGRP into migraine patients can elicit a delayed, migraine-like headache. Finally, CGRP receptor antagonists are clinically effective in providing relief to migraine patients. In addition to CGRP, the CGRP gene (CALCA) expresses another peptide that may also be relevant to migraine. Procalcitonin (proCT) is a recognized biomarker for sepsis, but emerging evidence suggests it may have actions similar to CGRP in migraine. First, proCT has biological activity at the CGRP receptor. Second, proCT is reported to be increased during migraine. We hypothesized that regulation of CGRP and proCT may be altered in migraineurs, and that migraineurs may also be sensitized to the effects of these peptides. To study the role of these peptides in migraine pathways, a number of methods have been employed. Studies exploring regulation of gene expression were performed in cultured trigeminal ganglia, as well as primary cultures of trigeminal and cortical glia. These studies show that the Calca gene can be regulated by a number of stimuli, including hypoxia and reactive oxygen species. These insults have the ability to induce CALCA gene and peptide expression to varying degrees on different cell types. In addition to in vitro experiments on Calca gene regulation, the in vivo effects of CGRP on mouse behavior were also investigated. Animals were genetically sensitized to CGRP via overexpression of the rate-limiting CGRP receptor subunit. In these animals, injection of CGRP is sufficient to induce light aversion, which is used to model photophobia. Physiological and biochemical triggers of migraine were tested using this behavioral paradigm. While stress and mast cell degranulation are sufficient to induce light aversion, the role of CGRP in these events remains unclear, as both CGRP sensitized and control animals displayed a light aversion phenotype. Together, these studies show the dynamic regulation of the Calca gene in migraine pathways as well as highlight some of the challenges of modeling a complex disease in an animal model.
- 29 November 2018
- Published by The University of Iowa
Regulation of CGRP gene expression and effects on light aversive behavior
Migraine is a debilitating neurological disorder, which affects over 10% of the general population. In addition to headache, migraine includes a host of associated symptoms, such as nausea and hypersensitivity to light, noise, and touch. While great strides have been made in migraine treatment in recent decades, the basic biological and pathophysiological mechanisms underlying migraine are still not well understood. Pain signals travel via a polysynaptic pathway from the periphery to the cortex, where conscious perception of pain occurs. This multi-neuron pathway produces a message that can be modified at any step of its transit. One peptide that may modify this pathway is calcitonin gene-related peptide (CGRP). CGRP is a potent vasodilator and neuromodulator, and mounting evidence suggests CGRP may play a causative role in migraine. CGRP levels are increased during migraine, but can be reduced upon successful treatment with drugs in the triptan class. Importantly, injection of CGRP into migraine patients can elicit a delayed, migraine-like headache. Finally, CGRP receptor antagonists are clinically effective in providing relief to migraine patients. In addition to CGRP, the CGRP gene (CALCA) expresses another peptide that may also be relevant to migraine. Procalcitonin (proCT) is a recognized biomarker for sepsis, but emerging evidence suggests it may have actions similar to CGRP in migraine. First, proCT has biological activity at the CGRP receptor. Second, proCT is reported to be increased during migraine. We hypothesized that regulation of CGRP and proCT may be altered in migraineurs, and that migraineurs may also be sensitized to the effects of these peptides. To study the role of these peptides in migraine pathways, a number of methods have been employed. Studies exploring regulation of gene expression were performed in cultured trigeminal ganglia, as well as primary cultures of trigeminal and cortical glia. These studies show that the Calca gene can be regulated by a number of stimuli, including hypoxia and reactive oxygen species. These insults have the ability to induce CALCA gene and peptide expression to varying degrees on different cell types. In addition to in vitro experiments on Calca gene regulation, the in vivo effects of CGRP on mouse behavior were also investigated. Animals were genetically sensitized to CGRP via overexpression of the rate-limiting CGRP receptor subunit. In these animals, injection of CGRP is sufficient to induce light aversion, which is used to model photophobia. Physiological and biochemical triggers of migraine were tested using this behavioral paradigm. While stress and mast cell degranulation are sufficient to induce light aversion, the role of CGRP in these events remains unclear, as both CGRP sensitized and control animals displayed a light aversion phenotype. Together, these studies show the dynamic regulation of the Calca gene in migraine pathways as well as highlight some of the challenges of modeling a complex disease in an animal model.
- 29 November 2018
- Published by The University of Iowa
Genetic studies of SH3PXD2B and its contributions to ocular diseases
In cultured cells, the adaptor protein SH3PXD2B is capable of recruiting a variety of proteins involved in invadosome assembly and function. It is therefore considered as an essential organizer of invadosomes active in cellular responses that require extracellular matrix degradation. Despite increasing knowledge about its properties and functions at the molecular and cellular levels, its physiological role in whole animals has not previously been assessed. Here, we present that SH3PXD2B is essential for normal postnatal development and disrupting SH3PXD2B can lead to glaucoma.Our work on SH3PXD2B is based on nee, a spontaneous mutation in mice which arose on an inbred background. Mice homozygous for the nee mutation were initially noted to exhibit runted growth, craniofacial abnormalities and ocular defects. Our additional physiological characterization has uncovered skeletal abnormalities, hearing impairment, infertility and a form of lipodystrophy. Using genetic mapping and DNA sequencing, the cause of nee phenotypes was identified as a 1-bp deletion within the Sh3pxd2b gene on mouse Chromosome 11. The nee mutation is predicted to cause a frameshift and a protein truncation altering a portion of the third SH3 domain and deleting the entire fourth SH3 domain. Molecular analysis showed that the fourth SH3 domain of SH3PXD2B can interact with a transmembrane member of a disintegrin and metalloproteinase family of proteins, ADAM15, and that GFP tagged SH3PXD2B protein truncation mislocalizes to the nucleus. Therefore, the mutant allele likely disrupts the normal function of SH3PXD2B and leads to nee phenotypes.The initial ocular abnormalities of nee mutants suggested that they may develop glaucoma. To test this hypothesis, we performed detailed clinical and histological analyses. We find that nee mutants exhibit elevated intraocular pressure likely caused by a severe iridocorneal adhesion present early in development. During the same time that intraocular pressure becomes elevated, retinal ganglion cells are damaged and optic nerve degeneration ensues. These results demonstrate that nee mutants develop an early onset form of closed angle glaucoma. To test the potential involvement of SH3PXD2B in human diseases, DNA sequencing analysis has been initiated in patients with developmental, primary open angle and syndromic glaucoma, and several missense variations have been identified. In conclusion, my results demonstrate a critical role of SH3PXD2B in normal development of multiple tissues and suggest that mutations in SH3PXD2B may also contribute to glaucoma.
- 29 November 2018
- Published by The University of Iowa
Genetic studies of SH3PXD2B and its contributions to ocular diseases
In cultured cells, the adaptor protein SH3PXD2B is capable of recruiting a variety of proteins involved in invadosome assembly and function. It is therefore considered as an essential organizer of invadosomes active in cellular responses that require extracellular matrix degradation. Despite increasing knowledge about its properties and functions at the molecular and cellular levels, its physiological role in whole animals has not previously been assessed. Here, we present that SH3PXD2B is essential for normal postnatal development and disrupting SH3PXD2B can lead to glaucoma.Our work on SH3PXD2B is based on nee, a spontaneous mutation in mice which arose on an inbred background. Mice homozygous for the nee mutation were initially noted to exhibit runted growth, craniofacial abnormalities and ocular defects. Our additional physiological characterization has uncovered skeletal abnormalities, hearing impairment, infertility and a form of lipodystrophy. Using genetic mapping and DNA sequencing, the cause of nee phenotypes was identified as a 1-bp deletion within the Sh3pxd2b gene on mouse Chromosome 11. The nee mutation is predicted to cause a frameshift and a protein truncation altering a portion of the third SH3 domain and deleting the entire fourth SH3 domain. Molecular analysis showed that the fourth SH3 domain of SH3PXD2B can interact with a transmembrane member of a disintegrin and metalloproteinase family of proteins, ADAM15, and that GFP tagged SH3PXD2B protein truncation mislocalizes to the nucleus. Therefore, the mutant allele likely disrupts the normal function of SH3PXD2B and leads to nee phenotypes.The initial ocular abnormalities of nee mutants suggested that they may develop glaucoma. To test this hypothesis, we performed detailed clinical and histological analyses. We find that nee mutants exhibit elevated intraocular pressure likely caused by a severe iridocorneal adhesion present early in development. During the same time that intraocular pressure becomes elevated, retinal ganglion cells are damaged and optic nerve degeneration ensues. These results demonstrate that nee mutants develop an early onset form of closed angle glaucoma. To test the potential involvement of SH3PXD2B in human diseases, DNA sequencing analysis has been initiated in patients with developmental, primary open angle and syndromic glaucoma, and several missense variations have been identified. In conclusion, my results demonstrate a critical role of SH3PXD2B in normal development of multiple tissues and suggest that mutations in SH3PXD2B may also contribute to glaucoma.
- 29 November 2018
- Published by The University of Iowa
Genetic pathways of Lyst and exfoliation syndrome
Human eyes with exfoliation syndrome (XFS) exhibit a distinctive pattern of iris transillumination defects that are recapitulated in Lyst mutant mice carrying the beige allele. Here I present the identification and characterization of the B6-Lystbg-J mouse model of XFS, modifiers of Lyst mediated ocular phenotypes, mechanisms of intraocular pressure (IOP) pathology related to circadian rhythms, and mechanisms of iris transillumination defects in the B6-Lystbg-J mice. Clinical and histological analysis shows that the B6-Lystbg-J mice have multiple similarities to human XFS including: iris transillumination defects, production of an exfoliative-like material, and pronounced pigment dispersion. Despite these insults, Lyst mutation does not cause increased IOP or optic nerve damage within the context of a C57BL/6J genetic background. However, defects in the circadian rhythm regulation of IOP were identified. Sequence analysis identifies that the beige mutation is predicted to delete a single isoleucine from the WD40 domain of the LYST protein. I identified CSNK2B as a binding partner of LYST and showed that LYSTbg-J completely disrupts the interaction. CSNK2B function in regulating E-cadherin and β-catenin binding is subsequently disrupted. These results lead to a working hypothesis that aspects of the XFS phenotype involve LYST and CSNK2B pathways, likely influencing cell-cell adherens junctions. Epistasis experiments were used to test for genetic modifiers of Lyst, which demonstrated that albino Lyst mutant mice exhibited complete rescue of Lyst-dependent iris phenotypes. In a genetic background-driven approach, a DBA/2J strain of congenic mice was created. The DBA/2J background, which harbors multiple mutations influencing melanosomal-proteins, enhanced Lyst dependent iris phenotypes. Thus, both experimental approaches implicated melanosomes, a potential source of oxidative stress, as mechanistically contributory. Supporting a contributory role of oxidative damage, Lyst mutation resulted in genetic context sensitive changes in iris lipid hydroperoxide levels, being lowest in albino and highest in DBA/2J mice. These results identified an association between oxidative damage to lipid membranes and severity of Lyst-mediated phenotypes, uncovering a new mechanism contributing to pathophysiology involving LYST. In conclusion these results demonstrate that mutation of the Lyst gene can produce ocular features of human XFS and suggests that LYST or LYST-interacting genes may contribute to XFS.
- 29 November 2018
- Published by The University of Iowa
Genetic pathways of Lyst and exfoliation syndrome
Human eyes with exfoliation syndrome (XFS) exhibit a distinctive pattern of iris transillumination defects that are recapitulated in Lyst mutant mice carrying the beige allele. Here I present the identification and characterization of the B6-Lystbg-J mouse model of XFS, modifiers of Lyst mediated ocular phenotypes, mechanisms of intraocular pressure (IOP) pathology related to circadian rhythms, and mechanisms of iris transillumination defects in the B6-Lystbg-J mice. Clinical and histological analysis shows that the B6-Lystbg-J mice have multiple similarities to human XFS including: iris transillumination defects, production of an exfoliative-like material, and pronounced pigment dispersion. Despite these insults, Lyst mutation does not cause increased IOP or optic nerve damage within the context of a C57BL/6J genetic background. However, defects in the circadian rhythm regulation of IOP were identified. Sequence analysis identifies that the beige mutation is predicted to delete a single isoleucine from the WD40 domain of the LYST protein. I identified CSNK2B as a binding partner of LYST and showed that LYSTbg-J completely disrupts the interaction. CSNK2B function in regulating E-cadherin and β-catenin binding is subsequently disrupted. These results lead to a working hypothesis that aspects of the XFS phenotype involve LYST and CSNK2B pathways, likely influencing cell-cell adherens junctions. Epistasis experiments were used to test for genetic modifiers of Lyst, which demonstrated that albino Lyst mutant mice exhibited complete rescue of Lyst-dependent iris phenotypes. In a genetic background-driven approach, a DBA/2J strain of congenic mice was created. The DBA/2J background, which harbors multiple mutations influencing melanosomal-proteins, enhanced Lyst dependent iris phenotypes. Thus, both experimental approaches implicated melanosomes, a potential source of oxidative stress, as mechanistically contributory. Supporting a contributory role of oxidative damage, Lyst mutation resulted in genetic context sensitive changes in iris lipid hydroperoxide levels, being lowest in albino and highest in DBA/2J mice. These results identified an association between oxidative damage to lipid membranes and severity of Lyst-mediated phenotypes, uncovering a new mechanism contributing to pathophysiology involving LYST. In conclusion these results demonstrate that mutation of the Lyst gene can produce ocular features of human XFS and suggests that LYST or LYST-interacting genes may contribute to XFS.
- 29 November 2018
- Published by The University of Iowa
MicroRNAs' role in brain development and disease
MicroRNA (miRNA) function is required for normal animal development, in particular in stem cell and precursor populations. I hypothesize that miRNAs are similarly required for stem cell maintenance and appropriate fate commitment in the brain. To test the requirement for global microRNA production, I depleted the microRNA biosynthetic enzyme DICER in the developing mouse brain. I found that DICER loss in embryonic neural progenitor cells leads to embryonic lethality with microcephaly. By histological analysis, I found defects in both neural progenitor cell maintenance and cell differentiation. I also identified new candidate microRNAs for this phenotype by profiling miRNAs in DICER-depleted and control cells. Three microRNAs which are good candidates to modulate nervous differentiation are miR-23b, -182, and -34a. I describe the expression pattern and functional characterization of these candidates. In particular, miR-34a depletes neuron production after progenitor cell differentiation in culture, likely by modulating cell cycling and Notch pathway genes.
- 29 November 2018
- Published by The University of Iowa
MicroRNAs' role in brain development and disease
MicroRNA (miRNA) function is required for normal animal development, in particular in stem cell and precursor populations. I hypothesize that miRNAs are similarly required for stem cell maintenance and appropriate fate commitment in the brain. To test the requirement for global microRNA production, I depleted the microRNA biosynthetic enzyme DICER in the developing mouse brain. I found that DICER loss in embryonic neural progenitor cells leads to embryonic lethality with microcephaly. By histological analysis, I found defects in both neural progenitor cell maintenance and cell differentiation. I also identified new candidate microRNAs for this phenotype by profiling miRNAs in DICER-depleted and control cells. Three microRNAs which are good candidates to modulate nervous differentiation are miR-23b, -182, and -34a. I describe the expression pattern and functional characterization of these candidates. In particular, miR-34a depletes neuron production after progenitor cell differentiation in culture, likely by modulating cell cycling and Notch pathway genes.